Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease

被引:847
作者
Yamamoto, A [1 ]
Lucas, JJ [1 ]
Hen, R [1 ]
机构
[1] Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA
关键词
D O I
10.1016/S0092-8674(00)80623-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Neurodegenerative disorders like Huntington's disease (HD) are characterized by progressive and putative irreversible clinical and neuropathological symptoms, including neuronal protein aggregates. Conditional transgenic models of neurodegenerative diseases therefore could be a powerful means to explore the relationship between mutant protein expression and progression of the disease. We have created a conditional model of HD by using the tet-regulatable system. Mice expressing a mutated huntingtin fragment demonstrate neuronal inclusions, characteristic neuropathology, and progressive motor dysfunction. Blockade of expression in symptomatic mice leads to a disappearance of inclusions and an amelioration of the behavioral phenotype. We thus demonstrate that a continuous influx of the mutant protein is required to maintain inclusions and symptoms, raising the possibility that HD may be reversible.
引用
收藏
页码:57 / 66
页数:10
相关论文
共 54 条
[1]   Ubiquitin, cellular inclusions and their role in neurodegeneration [J].
Alves-Rodrigues, A ;
Gregori, L ;
Figueiredo-Pereira, ME .
TRENDS IN NEUROSCIENCES, 1998, 21 (12) :516-520
[2]   STRUCTURE AND EXPRESSION OF THE HUNTINGTONS-DISEASE GENE - EVIDENCE AGAINST SIMPLE INACTIVATION DUE TO AN EXPANDED CAG REPEAT [J].
AMBROSE, CM ;
DUYAO, MP ;
BARNES, G ;
BATES, GP ;
LIN, CS ;
SRINIDHI, J ;
BAXENDALE, S ;
HUMMERICH, H ;
LEHRACH, H ;
ALTHERR, M ;
WASMUTH, J ;
BUCKLER, A ;
CHURCH, D ;
HOUSMAN, D ;
BERKS, M ;
MICKLEM, G ;
DURBIN, R ;
DODGE, A ;
READ, A ;
GUSELLA, J ;
MACDONALD, ME .
SOMATIC CELL AND MOLECULAR GENETICS, 1994, 20 (01) :27-38
[3]   Dopamine D-1 and D-2 receptor gene expression in the striatum in Huntington's disease [J].
Augood, SJ ;
Faull, RLM ;
Emson, PC .
ANNALS OF NEUROLOGY, 1997, 42 (02) :215-221
[4]   REDUCED BASAL GANGLIA VOLUME ASSOCIATED WITH THE GENE FOR HUNTINGTONS-DISEASE IN ASYMPTOMATIC AT-RISK PERSONS [J].
AYLWARD, EH ;
BRANDT, J ;
CODORI, AM ;
MANGUS, RS ;
BARTA, PE ;
HARRIS, GJ .
NEUROLOGY, 1994, 44 (05) :823-828
[5]   Cognitive deficits in Huntington's disease are predicted by dopaminergic PET markers and brain volumes [J].
Bäckman, L ;
Robins-Wahlin, TB ;
Lundin, A ;
Ginovart, N ;
Farde, L .
BRAIN, 1997, 120 :2207-2217
[6]   COREGULATION OF 2 GENE ACTIVITIES BY TETRACYCLINE VIA A BIDIRECTIONAL PROMOTER [J].
BARON, U ;
FREUNDLIEB, S ;
GOSSEN, M ;
BUJARD, H .
NUCLEIC ACIDS RESEARCH, 1995, 23 (17) :3605-3606
[7]   Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: Correlation between the density of inclusions and IT15 CAG triplet repeat length [J].
Becher, MW ;
Kotzuk, JA ;
Sharp, AH ;
Davies, SW ;
Bates, GP ;
Price, DL ;
Ross, CA .
NEUROBIOLOGY OF DISEASE, 1998, 4 (06) :387-397
[8]  
Carter RJ, 1999, J NEUROSCI, V19, P3248
[9]   Altered neurotransmitter receptor expression in transgenic mouse models of Huntington's disease [J].
Cha, JHJ ;
Frey, AS ;
Alsdorf, SA ;
Kerner, JA ;
Kosinski, CM ;
Mangiarini, L ;
Penney, JB ;
Davies, SW ;
Bates, GP ;
Young, AB .
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 1999, 354 (1386) :981-989
[10]   Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human Huntington disease gene [J].
Cha, JHJ ;
Kosinski, CM ;
Kerner, JA ;
Alsdorf, SA ;
Mangiarini, L ;
Davies, SW ;
Penney, JB ;
Bates, GP ;
Young, AB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (11) :6480-6485